Company Filing History:

13 out of 1,432

Ube Industries, Inc.

patents

1 out of 1

Uise Industries, Ltd.

patent

1 out of 256

Produits Chimiques Ugine Kuhlmann

patents

Years Active: 1978-1992

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5171664 - Monoclonal antibody to okadaic acids, process for producing the (1992-12-15),

2. 5147783 - Methods to screen for ovarian cancer and myocardial infarction (1992-09-15),

3. 5115097 - Synthetic peptide from the carboxy terminal of human Mn-superoxide (1992-05-19),

4. 4910133 - Diagnostic test drug comprising monoclonal antibody to human (1990-03-20),

5. 4647551 - For producing ethylene glycol and/or a glycolic acid ester, catalyst (1987-03-03),

6. 4614728 - Catalyst composition for producing ethylene glycol and process for (1986-09-30),

7. 4585890 - Process for producing ethylene glycol and/or glycolic acid ester, (1986-04-29),

8. 4551565 - Process for the production of ethylene glycol and/or glycollic acid (1985-11-05),

9. 4511744 - Process for producing lower alkylene glycol, catalyst composition used (1985-04-16),

10. 4440873 - Process for producing ethylene glycol and/or glycolic acid ester, (1984-04-03),

11. 4409395 - Process for the production of glycollic acid esters (1983-10-11),

12. 4338471 - Process for preparing phenol (1982-07-06),

13. 4205010 - Method for the catalytical production of acrylonitrile (1980-05-27),

14. 4097518 - Method for the catalytic production of acrylonitrile (1978-06-27),

15. 4070390 - Method for the catalytical preparation of acrylonitrile (1978-01-24),

Title: Taizo Uda: Innovator in Monoclonal Antibody Research

Introduction

Taizo Uda is a prominent inventor based in Ube, Japan, known for his significant contributions to the field of monoclonal antibody research. With a total of 15 patents to his name, Uda has made remarkable advancements in the detection and treatment of various health conditions.

Latest Patents

Uda's latest patents include a monoclonal antibody to okadaic acids, which is crucial for assaying these acids. This invention involves a process for producing the monoclonal antibody by culturing a cell strain capable of producing it. Additionally, he has developed methods to screen for ovarian cancer and myocardial infarction, utilizing a monoclonal antibody against human manganese-superoxide dismutase. This antibody is characterized by its high specificity against human Mn-SOD and is produced through a unique cell line obtained by immunizing a mouse with human Mn-SOD.

Career Highlights

Throughout his career, Uda has worked with notable companies such as Ube Industries, Inc. and Uise Industries, Ltd. His work has significantly impacted the field of biotechnology, particularly in the development of diagnostic tools and therapeutic agents.

Collaborations

Uda has collaborated with esteemed colleagues, including Yasuo Nakamura and Koichi Hirai, to further enhance his research and innovations in monoclonal antibodies.

Conclusion

Taizo Uda's contributions to monoclonal antibody research have paved the way for advancements in medical diagnostics and treatment. His innovative spirit and dedication to science continue to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.